ABI1 antibodies are immunoreagents designed to detect and study the ABI1 protein, which regulates actin polymerization, cell adhesion, and tyrosine kinase signaling . These antibodies are widely used in techniques such as Western blot (WB), immunohistochemistry (IHC), and immunoprecipitation (IP) . ABI1 interacts with key proteins like SOS1, EPS8, c-Abl, and WAVE2, forming complexes that influence pathways such as Ras-to-Rac signaling and EGFR activation .
Interacting Protein | Functional Role |
---|---|
SOS1 | Ras-to-Rac signaling |
c-Abl | Tyrosine kinase activation |
WAVE2 | Actin polymerization |
STAT3/NF-κB | T-cell signaling |
Hepatocellular Carcinoma (HCC): ABI1 overexpression correlates with tumor growth, metastasis, and poor prognosis. Knockdown experiments show reduced proliferation and invasion in HCC cells .
Prostate and Breast Cancer: ABI1 interacts with androgen receptors (AR) and modulates transcriptional activity, influencing disease progression .
T-Cell Activation: ABI1 KO models reveal its role in suppressing T-cell exhaustion by regulating Lck/Fyn kinases, with implications for CAR T-cell therapy .
Cytokine Signaling: ABI1 modulates STAT3 and NF-κB pathways, affecting IL-2 secretion and immune synapse formation .
Asthma: ABI1 is upregulated in airway smooth muscle (ASM) cells from asthmatic patients, driving proliferation and airway remodeling .
ABI1 antibodies exhibit high specificity across human, mouse, and rat samples. Representative examples include:
Actin Dynamics: ABI1 knockdown reduces profilin-1 recruitment to lamellipodia, impairing cell migration .
Oncogenic Signaling: In HCC, ABI1 enhances SFK/STAT3/NF-κB pathways, promoting metastasis .
Asthma Therapy: ABI1 inhibition attenuates ASM thickening and airway hyperresponsiveness in murine models .
Cancer Prognostics: High ABI1 expression predicts poor survival in HCC and breast cancer .
ABI1 antibodies are pivotal for exploring its dual role as a tumor promoter or suppressor, depending on cellular context . Ongoing studies focus on targeting ABI1 to enhance CAR T-cell efficacy or mitigate asthma-related airway remodeling .